Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Return on Invested Capital: 2018-2019

Historic Return on Invested Capital for Akebia Therapeutics (AKBA) over the last 2 years, with Dec 2019 value amounting to -0.53%.

  • Akebia Therapeutics' Return on Invested Capital was N/A to 0.10% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.10%, marking a year-over-year change of. This contributed to the annual value of -0.53% for FY2019, which is 15.00% down from last year.
  • Per Akebia Therapeutics' latest filing, its Return on Invested Capital stood at -0.53% for FY2019, which was down 39.03% from -0.38% recorded in FY2018.
  • Akebia Therapeutics' 5-year Return on Invested Capital high stood at -0.38% for FY2018, and its period low was -0.53% during FY2019.
  • For the 2-year period, Akebia Therapeutics' Return on Invested Capital averaged around -0.46%, with its median value being -0.46% (2019).
  • Data for Akebia Therapeutics' Return on Invested Capital shows a maximum YoY fell of 15bps (in 2019) over the last 5 years.
  • Akebia Therapeutics' Return on Invested Capital (Yearly) stood at -0.38% in 2018, then decreased by 15bps to -0.53% in 2019.